Filter
14444
Filtered Results: 14444
Text search:
WHO
(
World
Health
Organization)
Featured
Recommendations
1282
New Publications
3380
Language
Document type
No document type
7450
Studies & Reports
2360
Guidelines
1754
Manuals
638
Fact sheets
608
Strategic & Response Plan
487
Training Material
282
Situation Updates
269
Infographics
157
Resource Platforms
148
Online Courses
116
Videos
87
Brochures
57
Dashboards/Maps
21
App
10
Countries / Regions
Global
699
India
486
Kenya
337
Sierra Leone
286
Nigeria
257
Liberia
255
Ethiopia
252
Uganda
249
Western and Central Europe
242
South Africa
238
Nepal
227
Myanmar / Burma
201
Latin America and the Carribbean
200
Syria
199
Africa
191
Bangladesh
175
Rwanda
174
Russia
174
Ukraine
171
Zambia
168
Malawi
161
Congo, Democratic Republic of
152
Tanzania
151
Ghana
144
Mozambique
117
Philippines
111
Eastern Europe
110
South Sudan
110
Indonesia
107
Middle East and North Africa
103
Brazil
102
Namibia
95
West and Central Africa
92
Yemen
91
Lesotho
89
South–East Asia Region
88
Zimbabwe
85
Guinea
85
Haiti
85
Senegal
83
Cambodia
83
East and Southern Africa
76
Germany
74
Asia
67
Venezuela
66
Burkina Faso
63
Colombia
55
Eastern Europe and Central Asia
54
Cameroon
53
Botswana
52
Angola
44
Pakistan
42
Eswatini/ Swaziland
40
Madagascar
39
Mali
38
Afghanistan
37
Sudan
37
Benin
35
Paraguay
34
Central African Republic
33
China
32
Somalia
32
Lebanon
31
Western Pacific Region
29
Vietnam
29
Jordan
28
Guinea-Bissau
26
Côte d’Ivoire / Ivory Coast
26
Tajikistan
25
Thailand
25
Niger
23
Peru
23
Iraq
21
Turkey
20
Argentina
20
Moldova
19
Chad
17
Albania
16
Laos
16
USA
16
Sri Lanka
16
Chile
15
Georgia
15
Mexico
13
Kazakhstan
13
North America
13
Armenia
12
Spain
12
Palestine
12
Libya
12
Ecuador
12
Kyrgyzstan
11
Burundi
11
Southern Africa
11
Bolivia
11
Egypt
11
North Macedonia
10
Togo
10
Iran
10
Saudi Arabia
10
Portugal
10
Belarus
10
Greece
10
Papua New Guinea
9
Romania
9
Timor Leste/ East Timor
7
El Salvador
7
Malaysia
7
Tunisia
7
Poland
7
Bhutan
7
Serbia
6
Gambia
6
Jamaica
6
Japan
6
Honduras
6
Guatemala
6
Estonia
5
Uzbekistan
5
Morocco
5
Italy
5
Hungary
5
Turkmenistan
5
France
5
Azerbaijan
5
Fiji
4
Congo-Brazzaville
4
Mauritania
4
United Kingdom
4
Djibouti
4
Switzerland
3
Canada
3
Singapore
3
Mongolia
3
Qatar
3
Croatia
3
Gabon
3
Uruguay
3
Mauritius
3
Israel
3
Bosnia and Herzegovina
3
Nicaragua
3
North Korea
2
Vanuatu
2
Bulgaria
2
Dominican Republic
2
Lithuania
2
Ireland
2
Denmark
2
Algeria
2
Slovakia
2
Cuba
2
Australia
1
Cape Verde
1
Belgium
1
Maldives
1
Norway
1
South Korea
1
Morocco
1
Latvia
1
Barbados
1
Eritrea
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
4983
Clinical Guidelines
1032
Public Health
793
Women & Child Health
716
Key Resources
612
Capacity Building
328
Pharmacy & Technologies
145
Annual Report MEDBOX
3
Toolboxes
COVID-19
1697
Mental Health
1074
HIV
984
TB
746
Disability
603
Planetary Health
509
Rapid Response
491
Ebola
480
NTDs
476
AMR
408
Conflict
401
Caregiver
397
NCDs
366
Refugee
270
Global Health Education
263
Pharmacy
222
Natural Hazards
190
Zika
155
Health Financing Toolbox
139
Cholera
118
Specific Hazards
82
Polio
82
Social Ethics
57
Typhoon
8
Health Financing
3
South Sudan
2
The WHO Guidelines on risk reduction of cognitive decline and dementia provide evidence-based recommendations on lifestyle behaviours and interventions to delay or prevent cognitive decline and dementia. These WHO Guidelines are an important tool for health care providers as well as governments, pol...
Module 5
Monitoring and Evaluation
October 2018
Module 5: Monitoring and evaluation. This module is for people responsible for monitoring PrEP programmes at the national and site levels. It provides information on how to monitor PrEP for safety and effectiveness, suggesting core and additiona...
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
Module 2
Community Educators and Advocates
July 2017
Module 2: Community educators and advocates. Community educators and advocates are needed to increase awareness about PrEP in their communities. This module provides information on PrEP that should be considered in community-led activities ...
Module 3
Counsellors
July 2017
Module 3: Counsellors. This module is for staff who counsel people as they consider PrEP or start taking PrEP and support them in coping with side-effects and adherence strategies. Those who counsel PrEP users may be lay, peer or professional counsellors and hea...
Module 4
Leaders
July 2017
Module 4: Leaders. This module aims to inform and update leaders and decision-makers about PrEP. It provides information on the benefits and limitations of PrEP so that they can consider how PrEP could be effectively implemented in their own settings. It also contai...
Module 6
Pharmacists
July 2017
Module 6: Pharmacists. This module is for pharmacists and people working in pharmacies. It provides information on the medicines used in PrEP, including on storage conditions. It gives suggestions for how pharmacists and pharmacy staff can monitor PrEP adherence...
Module 8
Site Planning
July 2017
Module 8: Site planning. This module is for people involved in organizing PrEP services at specific sites. It outlines the steps to be taken in planning a PrEP service and gives suggestions for personnel, infrastructure and commodities that could be considered...
Module 9
Strategic planning
July 2017
Module 9: Strategic planning. As WHO recommends offering PrEP to people at substantial HIV risk, this module offers public health guidance for policy-makers on how to prioritize services, in order to reach those who could benefit most from PrEP, and in wh...
Module 10
Testing providers
July 2017
Module 10: Testing providers. This module is for people who provide testing services at PrEP sites and laboratories. It offers guidance in selecting testing services, including screening of individuals before PrEP is initiated and monitoring while they ar...
Module 12:
Adolescents and young adults
July 2018
Module 12: Adolescents and young adults. This module is for people who are interested in providing PrEP services to older adolescents and young adults who are at substantial risk for HIV. It provides information on: factors that influence HIV...
Module 1q
PrEP users
July 2017
Module 11: PrEP users. This module provides information for people who are interested in taking PrEP to reduce their risk of acquiring HIV and people who are already taking PrEP – to support them in their choice and use of PrEP. This module gives ideas for cou...
The primary audience of these recommendations includes healthcare providers who are responsible for developing national and local health protocols (particularly those related to hypertensive disorders of pregnancy), and those directly providing care to pregnant women and their newborns, including mi...
The Millennium Development Goals (MDGs) showed
that global commitment and collective action
could significantly reduce the disease burdens of
three deadly communicable diseases: HIV/AIDS,
tuberculosis (TB) and malaria. The MDGs helped
focus efforts on these three deadly diseases
and leveraged ...
The WHO Guidelines on physical activity and sedentary behaviour provide evidence-based public health recommendations for children, adolescents, adults and older adults on the amount of physical activity (frequency, intensity and duration) required to offer significant health benefits and mitigate he...
WHO has a unique combination of technical public health and scientific expertise, and a global operational footprint, with field offices in more than 150 countries. In 2020, this global, technical, and operational reach meant WHO was able to support countries around the world in every aspect of COVI...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that demand from Member States and is anchored in public health guiding principles in the human health sect...
WHO list of priority medical devices for management of cardiovascular diseases and diabetes
recommended
This publication was developed in response to the need for a reference list of priority medical devices required for management of noncommunicable diseases (NCDs), focusing on cardiovascular diseases and diabetes, especially for low- and middle-income countries to support universal health coverage a...
